Recombinant Factor VIIa for Rapid Reversal of Warfarin Anticoagulation in Acute Intracranial Hemorrhage
- 31 December 2004
- journal article
- research article
- Published by Elsevier BV in Mayo Clinic Proceedings
- Vol. 79 (12), 1495-1500
- https://doi.org/10.4065/79.12.1495
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The Effect of Warfarin and Intensity of Anticoagulation on Outcome of Intracerebral HemorrhageArchives of Internal Medicine, 2004
- Reversal of Warfarin-Induced Excessive Anticoagulation with Recombinant Human Factor VIIa ConcentrateAnnals of Internal Medicine, 2002
- Ongoing NovoSeven ® trialsIntensive Care Medicine, 2002
- Management and Prognostic Features of Intracerebral Hemorrhage During Anticoagulant Therapy: A Swedish Multicenter StudyStroke, 2001
- The ICH ScoreStroke, 2001
- What causes intracerebral hemorrhage during warfarin therapy?Neurology, 2000
- Early Surgical Treatment for Supratentorial Intracerebral HemorrhageStroke, 1999
- The ABCs of Measuring Intracerebral Hemorrhage VolumesStroke, 1996
- ASSESSMENT OF COMA AND IMPAIRED CONSCIOUSNESS: A Practical ScaleThe Lancet, 1974
- Cerebral Vascular Accidents in Patients over the Age of 60: II. PrognosisScottish Medical Journal, 1957